Cargando…

Characterization of human kallikrein 6/prostease M expression in ovarian cancer

Detalles Bibliográficos
Autores principales:	Ni, X, Zhang, W, Huang, K-C, Wang, Y, Ng, S-K, Mok, S C, Berkowitz, R S, Ng, S-W
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2005
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361923/ http://dx.doi.org/10.1038/sj.bjc.6602508

Ejemplares similares

Characterisation of human kallikrein 6/protease M expression in ovarian cancer
por: Ni, X, et al.
Publicado: (2004)

Validating genetic risk associations for ovarian cancer through the International Ovarian Cancer Association Consortium
por: Pearce, C L, et al.
Publicado: (2009)

Characterization of the structure and expression of mouse Itpa gene and its related sequences in the mouse genome
por: Behmanesh, M., et al.
Publicado: (2015)

Transcriptional upregulation of human tissue kallikrein 6 in ovarian cancer: clinical and mechanistic aspects
por: Shan, S J C, et al.
Publicado: (2007)

Corrigendum to ‘Unusual high number of spike protein mutations for the SARS-CoV-2 strains detected in Hong Kong’[Journal of Clinical Virology 148 (2022) 105081]
por: Tsang, Alan K.L., et al.
Publicado: (2022)

Prospective study of predictors of vitamin D status and survival in patients with colorectal cancer
por: Ng, K, et al.
Publicado: (2010)

Pre-operative evaluation of circulating KL-6 levels as a biomarker for epithelial ovarian carcinoma and its correlation with tumor MUC1 expression
por: Sato, Sho, et al.
Publicado: (2017)

Genetic regulation of Nrnx1 expression: an integrative cross-species analysis of schizophrenia candidate genes
por: Mozhui, K, et al.
Publicado: (2011)

Upregulated LINC00565 Accelerates Ovarian Cancer Progression by Targeting GAS6 [Corrigendum]
Publicado: (2020)

Ovarian cancer in younger vs older women: a population-based analysis
por: Chan, J K, et al.
Publicado: (2007)

LSD1 negatively regulates autophagy through the mTOR signaling pathway in ovarian cancer cells
por: Wei, Ye, et al.
Publicado: (2018)

Nucleolin binds to a subset of selenoprotein mRNAs and regulates their expression
por: Miniard, Angela C., et al.
Publicado: (2011)

Akt/mTOR-Mediated Autophagy Confers Resistance To BET Inhibitor JQ1 In Ovarian Cancer [Corrigendum]
Publicado: (2019)

The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro
por: O'Brien, P M, et al.
Publicado: (2008)

Impact of vitamin D supplementation on adiposity in African-Americans
por: Chandler, P D, et al.
Publicado: (2015)

Metastasis of ovarian cancer is mediated by kallikrein related peptidases
por: Dong, Ying, et al.
Publicado: (2013)

Corrigendum: Effect of Dandelion Extracts on the Proliferation of Ovarian Granulosa Cells and Expression of Hormone Receptors
Publicado: (2018)

Corrigendum to “Study of hydrosalpinx on endometrial growth and expression of HOXA10mRNA and related factors” [Heliyon 9(6) (June 2023) e17063]
por: Li, Taolan, et al.
Publicado: (2023)

Kallikreins 5, 6 and 10 Differentially Alter Pathophysiology and Overall Survival in an Ovarian Cancer Xenograft Model
por: Pépin, David, et al.
Publicado: (2011)

Phenotypic modifications in ovarian cancer stem cells following Paclitaxel treatment
por: Craveiro, Vinicius, et al.
Publicado: (2013)

Granulocyte colony-stimulating factor receptor signalling via Janus kinase 2/signal transducer and activator of transcription 3 in ovarian cancer
por: Kumar, J, et al.
Publicado: (2015)

Characterization of kallikrein-related peptidase 4 (KLK4) mRNA expression in tumor tissue of advanced high-grade serous ovarian cancer patients
por: Gong, Weiwei, et al.
Publicado: (2019)

Three dysregulated miRNAs control kallikrein 10 expression and cell proliferation in ovarian cancer
por: White, N M A, et al.
Publicado: (2010)

ING1 induces apoptosis through direct effects at the mitochondria
por: Bose, P, et al.
Publicado: (2013)

Corrigendum to: EGFR mediates LPA‐induced proteolytic enzyme expression and ovarian cancer invasion: Inhibition by resveratrol
Publicado: (2019)

Expression and function of the Kallikrein-related peptidase 6 in the human melanoma microenvironment
por: Krenzer, Stefanie, et al.
Publicado: (2011)

Expression and biological significance of human kallikrein 6 in gastric cancer tissues
por: Hu, Cheng Jin, et al.
Publicado: (2013)

[Corrigendum] Lidocaine inhibits the invasion and migration of TRPV6‑expressing cancer cells by TRPV6 downregulation
por: Jiang, Yuan, et al.
Publicado: (2023)

[Corrigendum] METTL3‑mediated m6A modification of Bcl‑2 mRNA promotes non‑small cell lung cancer progression
por: Zhang, Yongxi, et al.
Publicado: (2023)

Loss of connective tissue growth factor as an unfavorable prognosis factor activates miR-18b by PI3K/AKT/C-Jun and C-Myc and promotes cell growth in nasopharyngeal carcinoma
por: Yu, X, et al.
Publicado: (2013)

The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions
por: Antoniou, A C, et al.
Publicado: (2008)

Altered expression of miR-152 and miR-148a in ovarian cancer is related to cell proliferation
por: Zhou, Xin, et al.
Publicado: (2022)

Corrigendum to: “Characterization of Sphingomyelin Phosphodiesterase Expression in Bumblebee (Bombus lantschouensis)”
Publicado: (2019)

Cucurbitacin IIa: a novel class of anti-cancer drug inducing non-reversible actin aggregation and inhibiting survivin independent of JAK2/STAT3 phosphorylation
por: Boykin, C, et al.
Publicado: (2012)

A 19-miRNA Support Vector Machine classifier and a 6-miRNA risk score system designed for ovarian cancer patients
por: Dong, Jingwei, et al.
Publicado: (2019)

Expression and prognostic significance of TRPV6 in the development and progression of pancreatic cancer
por: Song, He, et al.
Publicado: (2022)

Corrigendum to “Cell therapies in ovarian cancer”
Publicado: (2021)

Suppression of cell-cycle progression by Jun dimerization protein-2 (JDP2) involves downregulation of cyclin-A2
por: Pan, J, et al.
Publicado: (2011)

Corrigendum to ‘Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer’ [EBioMedicine 38 (2018) 100–112]
por: Kanlikilicer, Pinar, et al.
Publicado: (2020)

Corrigendum to “Determine the Role of FSH Receptor Binding Inhibitor in Regulating Ovarian Follicles Development and Expression of FSHR and ERα in Mice”
por: Lai, Luju, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mkgcdnmtm8he06kskvi7kuj1oo